Viking Global Investors LP Blueprint Medicines Corp Call Options Transaction History
Viking Global Investors LP
- $25.8 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
350Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$736 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$732 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$593 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$436 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$304 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.57B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...